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Bovine viral diarrhea (BVD) is an OIE notifiable disease that has significant economic impact on 
the cattle industry world-wide. BVD is also an animal welfare concern; depending on the virus 
strain and host factors, the clinical manifestation of infection may vary from asymptomatic or 
mild to severe or even fatal disease. Consequences of infection may include reproduction 
failure, poor reproductive performance, and susceptibility to secondary infections due to the 
immunosuppressive effects of BVD. Persistently infected (PI) calves serves as a virus reservoir. 
BVDV is a pestivirus in the Flaviviridae family; BVDV-1 and BVDV-2 are recognized as unique 
species. Novel group of pestivirus, informally named BVDV-3 was described recently in bovine 
sera of South American and Asian origin. The presence of those atypical BVDVs in other 
continent is unknown, however without proper control measures, the virus contaminating 
veterinary reagents and vaccines could have spread further. Our study is the first one 
describing clinical outcome and dynamics of the infection of cattle with novel BVDV.  
 
The aim of this study was to characterize the competition between BVDV strains in vivo during 
an experimental study in young calves. To investigate virus replication dynamics, possible 
recombination events, clinical signs, and virus transmission in calves infected with BVDV. 
Additional objective was to validate detection system for atypical BVDVs. The experiment 
included groups of five 5-6 months old, BVD negative calves. The groups were: 
 
1. BVDV-1 group: inoculated with BVDV type 1  
2. BVDV-3 group: inoculated with the novel atypical strain Th/04_KhonKaen  
3. BVDV 1&3 group: inoculated with a mixture of BVDV 1 and 3  
4. Control group: inoculated with Eagles MEM  
 
Each animal in group 1-3 received 5 ml of 105 TCID50 of inoculum i.m. and 5 ml intranasally.  
 
Serum samples from all the calves were tested for presence of virus and antibodies. The virus 
population and replication dynamics were quantified by real-time RT-PCR, sequence analysis. 
The calves were euthanized post infection day (PID) 42, necropsy performed and tissues 
collected.  
 
Preliminary results indicate that experimental inoculations in all three groups were successful 
based on antibody response, virus shedding, clinical picture and blood analysis. Pyrexia was 
observed in BVDV-1 and BVDV-3 groups on PID 7-9 while in BVDV 1&3 PID 7-10. Statistically 
significant decreases in white blood cell counts were observed PID 5 in BVDV-1 and BVDV-3 
groups; PID 7 in BVDV 1&3 group and PID 14 in BVDV-1 and BVDV 1&3 groups. Significant 
decreases of lymphocyte counts were observed in all virus infected groups on PID 2-5-7. 
Viraemia based on antigen ELISA on serum samples was observed in all three inoculated 
groups between PID 5 and 9 with the maximum O.D. values on PID 7. Immune response 
based on ELISA test for antibodies (O.D. values above cut off) was detected PID14 in BVDV-1 
group and PID 21 in BVDV-3 and BVDV 1&3 groups. While O.D. values for BVDV-1 and BVDV 
1&3 groups were similar, the readings for BVDV-3 were almost 50% lower between PID 21 and 
42. Ongoing analysis is directed towards strain specific real time RT-PCR to quantify viral RNA 
loads in the blood and nose swabs, virus neutralization test against homo- and heterologous 
virus strains and virus detection in cell culture. Specific cellular and humoral immune response 
would be also evaluated based on cytokine and T-cell responses. The result will be presented. 
  
